Recommendations for the implementation of BRCA testing in the care and treatment pathways of ovarian cancer patients

Carmine Pinto, Maria Angela Bella, Ettore Capoluongo, Paola Carrera, Claudio Clemente, Nicoletta Colombo, Laura Cortesi, Gaetano De Rosa, Francesca Fenizia, Maurizio Genuardi, Stefania Gori, Valentina Guarneri, Antonio Marchetti, Paolo Marchetti, Nicola Normanno, Barbara Pasini, Sandro Pignata, Paolo Radice, Enrico Ricevuto, Antonio RussoPierosandro Tagliaferri, Pierfrancesco Tassone, Mauro Truini, Liliana Varesco

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)2071-2075
Number of pages5
JournalFuture Oncology
Volume12
Issue number18
DOIs
Publication statusPublished - Sep 1 2016

Keywords

  • BRCA1
  • BRCA2
  • genetic testing
  • germline mutations
  • ovarian cancer
  • PARP inhibitors
  • somatic mutations

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Pinto, C., Bella, M. A., Capoluongo, E., Carrera, P., Clemente, C., Colombo, N., Cortesi, L., De Rosa, G., Fenizia, F., Genuardi, M., Gori, S., Guarneri, V., Marchetti, A., Marchetti, P., Normanno, N., Pasini, B., Pignata, S., Radice, P., Ricevuto, E., ... Varesco, L. (2016). Recommendations for the implementation of BRCA testing in the care and treatment pathways of ovarian cancer patients. Future Oncology, 12(18), 2071-2075. https://doi.org/10.2217/fon-2016-0189